Mojca Lunder

Title: Mojca Lunder: Innovator in Allergy Research

Introduction

Mojca Lunder is a prominent inventor based in Ljubljana, Slovenia. She has made significant contributions to the field of allergy research, particularly through her innovative patents. With a total of 3 patents, her work focuses on developing therapeutic solutions for allergic reactions.

Latest Patents

One of her latest patents is titled "IgE epitope-like peptides and uses thereof." This invention relates to peptides that can bind to allergen-specific IgE paratopes, which are crucial in the allergic response. By covering the paratopes of IgE bound on effector cells, these peptides prevent the binding of causative allergens, thereby inhibiting degranulation and the secretion of mediators of allergic inflammation. This method offers a promising therapeutic approach for managing allergic reactions caused by exposure to allergens.

Another significant patent is "Affinity ligands for antibody Fc region." This invention involves peptide compounds, peptoids, or retro-inverso analogues that exhibit binding affinity for the Fc region of immunoglobulins. The applications of these peptides include purification of immunoglobulins through affinity chromatography, non-covalent antibody labeling, antibody detection, and immobilization of antibodies to solid supports.

Career Highlights

Mojca Lunder has worked with esteemed institutions such as the University of Ljubljana and the Institute Jozef Stefan. Her research and innovations have garnered attention in the scientific community, contributing to advancements in allergy treatment.

Collaborations

Throughout her career, she has collaborated with notable colleagues, including Matjaz Ravnikar and Borut Strukelj. These partnerships have further enriched her research and expanded the impact of her inventions.

Conclusion

Mojca Lunder's work exemplifies the intersection of innovation and practical application in allergy research. Her patents not only advance scientific understanding but also offer potential solutions for those affected by allergies.